Frontier Biotechnologies Inc. (SHA:688221)
China flag China · Delayed Price · Currency is CNY
21.10
-0.40 (-1.86%)
At close: Apr 29, 2026

Frontier Biotechnologies Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2017
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2017
Cash & Equivalents
187.6170.34248.98526.66550.89800.85
Upgrade
Trading Asset Securities
542.12542.79600.53415.06690.11679.36
Upgrade
Cash & Short-Term Investments
729.72713.14849.51941.721,2411,480
Upgrade
Cash Growth
-2.20%-16.05%-9.79%-24.12%-16.16%-16.78%
Upgrade
Accounts Receivable
43.2958.4934.7563.0136.1422.34
Upgrade
Other Receivables
134.15133.6227.72.3710.551.13
Upgrade
Receivables
177.44192.09262.4565.3846.6823.48
Upgrade
Inventory
78.266.6241.065955.6138.62
Upgrade
Other Current Assets
302.4632.9769.636.6862.7835.2
Upgrade
Total Current Assets
1,2881,0051,2231,1031,4061,578
Upgrade
Property, Plant & Equipment
417.38423.23393.31793.02728.06605.76
Upgrade
Long-Term Investments
20.6921.2729.96---
Upgrade
Other Intangible Assets
122.18127.55149.32229.18257.22258.44
Upgrade
Long-Term Deferred Charges
2.041.442.030.942.743.12
Upgrade
Other Long-Term Assets
0.34-14.8914.2116.7687.8
Upgrade
Total Assets
1,8501,5781,8122,1402,4112,533
Upgrade
Accounts Payable
30.8147.060.881.132.693.32
Upgrade
Accrued Expenses
10.6318.5225.1137.3941.8438.98
Upgrade
Short-Term Debt
285.32249.71283.97202.3110.6452.19
Upgrade
Current Portion of Long-Term Debt
13.5376.3343.01104.0646227.77
Upgrade
Current Portion of Leases
--0.232.44.425.09
Upgrade
Current Income Taxes Payable
1.150.93----
Upgrade
Current Unearned Revenue
12.591.782.685.830.06-
Upgrade
Other Current Liabilities
9.761639.3427.0471.5872.14
Upgrade
Total Current Liabilities
363.78410.34395.2380.16277.23399.49
Upgrade
Long-Term Debt
172.5182.8679.3671.42117.127.5
Upgrade
Long-Term Leases
0.24--0.170.450.41
Upgrade
Long-Term Unearned Revenue
56.3859.03196.26329.35323.54269.41
Upgrade
Other Long-Term Liabilities
149.26149.21-16.3521.0825.59
Upgrade
Total Liabilities
742.17701.44670.83797.44739.41702.41
Upgrade
Common Stock
374.58374.58374.58374.58374.58359.76
Upgrade
Additional Paid-In Capital
2,7312,7272,7232,7232,7232,540
Upgrade
Retained Earnings
-1,997-2,225-1,956-1,755-1,426-1,069
Upgrade
Comprehensive Income & Other
0.080.040.020.010.03-0.05
Upgrade
Total Common Equity
1,108876.871,1411,3431,6711,830
Upgrade
Shareholders' Equity
1,108876.871,1411,3431,6711,830
Upgrade
Total Liabilities & Equity
1,8501,5781,8122,1402,4112,533
Upgrade
Total Debt
471.59408.9406.56380.35278.62292.96
Upgrade
Net Cash (Debt)
258.13304.24442.95561.37962.381,187
Upgrade
Net Cash Growth
-29.29%-31.32%-21.09%-41.67%-18.94%-32.01%
Upgrade
Net Cash Per Share
0.690.821.191.502.643.29
Upgrade
Filing Date Shares Outstanding
372.78374.58374.58374.58374.58359.76
Upgrade
Total Common Shares Outstanding
372.78374.58374.58374.58374.58359.76
Upgrade
Working Capital
924.04594.48827.41722.631,1291,178
Upgrade
Book Value Per Share
2.972.343.053.584.465.09
Upgrade
Tangible Book Value
986.1749.32991.991,1141,4141,572
Upgrade
Tangible Book Value Per Share
2.652.002.652.973.784.37
Upgrade
Buildings
--159.0676.2276.22-
Upgrade
Machinery
--127.7347.3545.9230.44
Upgrade
Construction In Progress
--147.74695.97622.9582.29
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.